Related Experiment Video
Updated: Mar 9, 2026

Author Spotlight: Accelerating Diagnostic Accuracy with Direct Identification of Gram-Negatives from Blood Culture Bottles
Published on: May 24, 2024
Minor non-fermenting Gram-negative bacilli in Europe, 2020-2024 (MINOFEu).
Gabriele Bianco1, Paulo Bastos2, Konstantina Gartzonika3
1Department of Experimental Medicine, University of Salento, Lecce, Italy; Microbiology and Virology Unit, Vito Fazzi Hospital, Lecce, Italy.
This study highlights the epidemiology and antimicrobial resistance of minor non-fermenting Gram-negative bacilli (NFGNB) in European hospitals. Stenotrophomonas maltophilia and Achromobacter xylosoxidans showed significant resistance patterns, necessitating updated antimicrobial strategies.
Area of Science:
- Clinical Microbiology
- Infectious Diseases
- Antimicrobial Resistance
Background:
- Minor non-fermenting Gram-negative bacilli (NFGNB), excluding Pseudomonas and Acinetobacter, are underrepresented in European surveillance.
- Understanding their epidemiology and resistance is crucial for effective patient management.
Purpose of the Study:
- To investigate the diagnostic approaches, epidemiology, and antimicrobial susceptibility of minor NFGNB in European hospitals.
- To provide an updated overview supporting improved diagnostic and antimicrobial strategies.
Main Methods:
- Multicentre retrospective observational study of minor NFGNB isolates from blood cultures (2020-2024).
- Analysis of diagnostic methods (MALDI-TOF MS), epidemiology (polymicrobial cultures, catheter-related bloodstream infections), and antimicrobial susceptibility (EUCAST guidelines).
Main Results:
- 4,420 minor NFGNB isolates identified; Stenotrophomonas maltophilia (52.4%) and Achromobacter xylosoxidans (7.8%) were most prevalent.
- High resistance rates observed for S. maltophilia to sulfamethoxazole/trimethoprim (11%) and A. xylosoxidans to meropenem (10%) and piperacillin/tazobactam (24%).
- Species-specific susceptibility patterns noted, with S. paucimobilis showing high susceptibility to several beta-lactams and tetracycline.
Conclusions:
- This study offers a comprehensive European overview of minor NFGNB diagnostics and epidemiology.
- Findings support the need for updated diagnostic and antimicrobial strategies to combat resistance in these pathogens.
Related Concept Videos
Bacterial Phylum Firmicutes
Bacterial Phylum Bacteroidota
Bacterial Phylum Spirochaetes
Bacterial Phylum Proteobacteria
Bacterial Phylum Actinobacteria
Development of Antibiotic Resistance

